Effect of Pentoxifylline on Tumor Necrosis Factor and Reactive Oxygen Species Levels in Seminal Plasma in Idi-opathic Male Infertility
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 330
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
RROYAN20_292
تاریخ نمایه سازی: 29 مهر 1398
چکیده مقاله:
Background: Pentoxifylline is a methyl xanthine derivative that influences the sperm motion characteristics. It is commonly used in treatment of male-factor infertility, including astheno-zoospermia. The aim of this study was to evaluate any possible effect of Pentoxifylline on sperm characteristics ،TNF(Tumor Necrosis Factor) and ROS (Reactive Oxygen Species) Levels in Seminal Plasma in a group of patients with asthenozoospermia. Materials and Methods: 30 infertile men with asthenozoo-spermia were allocated to this study. A dosage of 400 mg pen-toxifylline / twice daily for duration of 3 months was adminis-tered to each patient. Two semen samples (one before and one after the pentoxifylline therapy) were evaluated under blind condition. Semen parameters ,TNF and ROS Levels( by hu-man TNF ELISA kit and Chemiluminescence assay- Agarwal respectively) in Seminal Plasma were analyzed ( pre and post intervention) for each sample. Data was analyzed statistically using one-way ANOVA and Tukey’s test .Results: Pentoxifylline increased significantly the mean sperm count and normal morphology in the men with asthenozoo-spermia when compared to pre-administration. pentoxifylline was significantly effective on the fast progressive motility of sperm (P<0.01). Based on the results, mean concentration (± S.D) of TNF in the seminal plasma was significantly in-creased in patients treated with pentoxifylline when compared to pre-administration. Moreover, ROS levels in seminal plasma of patients with asthenozoospermia decreased significantly compared to before administration of pentoxifylline.Conclusion: Although our results demonstrate that oral therapy of pentoxifylline significantly increase the quality of sperm, es-pecially motility from infertile men with asthenozoospermia, but more molecular studies are needed to elucidate the safety of pentoxifylline- administration.
کلیدواژه ها:
نویسندگان
Z Dadgar
Department of Biology, Arak university, Arak, Iran
M Soleimani Mehranjani
Department of Biology, Arak university, Arak, Iran
SMA Shariatzadeh
Department of Biology, Arak university, Arak, Iran
AR Kheirolahi
Department of Urology, Lorestan University of Medical Science, Khorram Abad, Iran